Morgan Stanley downgraded Novo Nordisk to underweight from equal-weight saying it sees slowing growth of its lucrative GLP-1 ...

Hy-Vee pharmacies to offer weight-loss drugs Ozempic and Wegovy at half-price to customers who are uninsured or whose ...

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss. Together, these blockbuster drugs made Novo the most valuable publicly ...

Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo ...

Wall Street analysts can't agree on Novo Nordisk (NYSE: NVO), with Morgan Stanley recently cutting its rating to underweight ...

Novo Nordisk said it is laying off about 11.5% of its workforce in a "transformation" of the drugmaker's business.

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling stocks.

Novo Nordisk (NVO) stock is in focus as a federal appeals court denies the company's bid to challenge Medicare drug pricing ...

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...

Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against ...